AviadoBio

AviadoBio is developing gene therapies for neurodegenerative diseases including frontotemporal dementia and amyotrophic lateral sclerosis. 

Sidley Healthcare Conference
Biotech

GSK aiming to ‘balance West and East’ since Hansoh deal success

GSK has been operating a strategy of “balancing the West and the East” since the Big Pharma’s collaboration with Hansoh, according to an executive.
James Waldron Sep 23, 2026 5:00am
Closeup of blue eye on black background

AviadoBio secures option to rare eye disease gene therapy

Oct 9, 2025 8:50am
Graphic of two hands shaking under a red and purple light

Astellas pays $50M for option on AviadoBio dementia gene therapy

Oct 8, 2024 7:40am
topic report
Fierce Biotech Fierce 15 logo

Fierce Biotech's 2022 Fierce 15

Sep 12, 2022 3:00am
CL chutes

2 Astellas execs to retire—Chutes & Ladders

Aug 5, 2022 9:46am
Gene therapy

AviadoBio gains orphan tag for one-dose dementia gene therapy

Apr 27, 2022 9:18am